Alteogen, Institutional Investors Sold Net 110,855 Shares in Last 5 Days... Stock Price 267,600 KRW (+2.76%)

Alteogen is trading at 267,600 KRW as of 9:30 AM on the 30th, up 2.76% from the previous day. The trading volume is 136,578 shares, which is about 17.27% of the previous day's volume. Alteogen is known as a biosimilar development company.

On June 25, Lee Dong-geon, a researcher at Shinhan Financial Investment, stated, "A large-scale license agreement worth 4.7 trillion KRW was signed with a global top 10 pharmaceutical company. This contract covers a total of six targets, with a structure to receive up to 776.3 billion KRW in milestones and royalties per target. Attention is drawn to the scalability of the company that signed the largest platform license agreement in Korea. In other words, the commercialization potential is higher compared to new drugs, and since only clinical phases 1 and 3 are conducted, the required time is significantly shorter." He set Alteogen’s target price at 340,000 KRW.

Over the past five days, individual investors have net purchased 98,523 shares of Alteogen, while foreigners and institutions have net purchased 18,748 shares and net sold 110,855 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.